News

In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Drugmaker Sarepta Therapeutics said it won’t comply with a request from the FDA to halt all shipments of its gene therapy ...
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug ...
Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.
Sarepta Therapeutics Inc has voluntarily paused shipments of Elevidys in the United States. The decision responds to FDA ...
Sarepta will stop shipping its Duchenne muscular dystrophy gene therapy Elevidys following ongoing discussions with the FDA over safety labeling. The drugmaker said the pause, effective July 22, will ...
Ukraine is moving forward with plans for joint weapons production with allies, while the U.S. halts some arms shipments it had promised to help Kyiv fight off Russia’s invasion ...
What You Need To Know Ukraine is moving forward with plans for joint weapons production with allies, while the U.S. halts some arms shipments it had promised to help Kyiv fight off Russia’s invasion ...